Paolo Bossi

45PUBLICATIONS
262CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Dental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Mar 23, 2026
Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|Feb 13, 2026
Outcomes for Sinonasal Undifferentiated Carcinoma (SNUC): An International Multi-Center Retrospective Cohort Study.

Jacklyn Liu, Yoko Takahashi, Umar Rehman

|Feb 10, 2026
Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Athénaïs van der Elst, Daniel Herrero-Saboya, Lucas Michon

|May 07, 2025
Are we doing enough to treat cancer pain? The urgent need for action in oncology practice.

Massimo Aglietta, Rossana Berardi, Guido Biasco

|Apr 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|Mar 26, 2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitis.

Funda Meric-Bernstam, Aditya Bardia, Paolo Bossi

Pageof 8

Frequent Collaborators

5 joint publications

Lisa Licitra

4 joint publications

Marco Ferrari

4 joint publications

Davide Mattavelli

4 joint publications

Laura Locati